Roche Holding EBITDA vs. Revenue
| RHHBF Stock | USD 285.76 9.24 3.13% |
For Roche Holding profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Roche Holding to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Roche Holding AG utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Roche Holding's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Roche Holding AG over time as well as its relative position and ranking within its peers.
Roche |
Roche Holding AG Revenue vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Roche Holding's current stock value. Our valuation model uses many indicators to compare Roche Holding value to that of its competitors to determine the firm's financial worth. Roche Holding AG is rated second in ebitda category among its peers. It also is rated second in revenue category among its peers totaling about 2.82 of Revenue per EBITDA. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Roche Holding's earnings, one of the primary drivers of an investment's value.Roche Revenue vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Roche Holding |
| = | 22.26 B |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Roche Holding |
| = | 62.8 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Roche Revenue vs Competition
Roche Holding AG is rated second in revenue category among its peers. Market size based on revenue of Drug Manufacturers—General industry is at this time estimated at about 564.2 Billion. Roche Holding retains roughly 62.8 Billion in revenue claiming about 11% of equities under Drug Manufacturers—General industry.
Roche Holding Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Roche Holding, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Roche Holding will eventually generate negative long term returns. The profitability progress is the general direction of Roche Holding's change in net profit over the period of time. It can combine multiple indicators of Roche Holding, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. ROCHE HOLDINGS operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 100920 people.
Roche Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Roche Holding. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Roche Holding position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Roche Holding's important profitability drivers and their relationship over time.
Use Roche Holding in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Roche Holding position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roche Holding will appreciate offsetting losses from the drop in the long position's value.Roche Holding Pair Trading
Roche Holding AG Pair Trading Analysis
The ability to find closely correlated positions to Roche Holding could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Roche Holding when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Roche Holding - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Roche Holding AG to buy it.
The correlation of Roche Holding is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Roche Holding moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Roche Holding AG moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Roche Holding can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Roche Holding position
In addition to having Roche Holding in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Exotic Funds Thematic Idea Now
Exotic Funds
Funds or Etfs with high minimum investment requirement that manage portfolios of alternative investments such as hedge funds, options, futures, real estate or commodities. The Exotic Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Exotic Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Roche OTC Stock
To fully project Roche Holding's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Roche Holding AG at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Roche Holding's income statement, its balance sheet, and the statement of cash flows.